One study found that taking antidepressants in pregnancy when needed reduces the risk of preterm birth by 16%. Meanwhile, the ...

In a new three-part docuseries streaming on The Roku Channel, “Solo Traveling with Tracee Ellis Ross,” a camera crew follows ...

The Food and Drug Administration hosted a panel focused almost entirely on the potential risks of taking drugs like ...

A panel organized by the FDA cast doubts on the safety of antidepressants during pregnancy — drawing ire from doctors who say ...

Dozens of lawmakers are urging U.S. health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks.

The U.S. drug regulator said on Friday a unit of Johnson & Johnson issued a correction for certain lots of a part related to its surgical stapler and classified the action as "most serious".

FDA's Makary commits to reviewing abortion pill mifepristone safety data while listening to concerns, stating he has no plans for policy changes.

Today, we discuss how Duchenne patients and their families are responding to the shelving of Sarepta Therapeutics’ gene therapy, see an FDA panel made up largely of SSRI skeptics lambast their ...

But the risks of untreated mental illness, especially during pregnancy, are serious, and tend to outweigh the small and uncertain risk of antidepressants harming unborn babies, experts told STAT.

On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications like fluoxetine (Prozac), sertraline (Zoloft) and citalopram (Celexa ...

An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of the drugs.

Food and Drug Administration (FDA) Commissioner Marty Makary said in an interview with Politico’s Dasha Burns that the FDA will “look at the data” surrounding the abortion drug, mifepristone ...